Velcade Mesothelioma (ICORG 05-10) Study
Results of the Velcade Mesothelioma (ICORG 05-10) Study have now been published in the Journal of Thoracic Oncology (September 2012 – Volume 7 – Issue 9)
Results of the Velcade Mesothelioma (ICORG 05-10) Study have now been published in the Journal of Thoracic Oncology (September 2012 – Volume 7 – Issue 9)
Congratulations to Dr Anne Horgan and the all of the team in Waterford Regional Hospital on the accrual of the first ICORG patient to this important study on the 27th August.
Are you interested in getting regular updates on Cancer Research in Ireland and Cancer related national and international news?
It has been announced that St James’s Hospital has been designated the National Centre for Oesphageal and Gastric Cancer with Professor John Reynolds appointed the Clinical Lead for Upper Gastrointestinal Cancer.
The EU issued, on 17th July 2012, the ‘Clinical Trials Regulation’ proposal which is anticipated to replace the Clinical Trials Directive 2001/20/EC in 2016.
ICORG exceeded their accrual target for IBCSG35-07 (SOLE) / ICORG 11-03 Study
ICORG has had an abstract accepted for ESMO 2012 on "Serum levels of VEGF pre- and post-treatment with bevacizumab for early stage breast cancer" [ICORG 08-10 Study]
The Fighting Cancer Triathlon took place on Saturday 16th June 2012 in Belvedere House & Gardens, Mullingar, Co Westmeath.
Recent data is indicating Everolimus in combination with a Hormonal therapy as a potential new combination treatment regime for advanced breast cancer patients.
ICORG’s Leading Role in Cancer Research in Ireland recognised by Irish Medicines Board.